COMMUNIQUÉS West-GlobeNewswire

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

24/02/2025 - 22:05

CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational [...]

SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance

24/02/2025 - 22:09

Achieves 26% worldwide revenue growth and positive adjusted EBITDA in Fourth Quarter 2024 SANTA CLARA, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving [...]

BridgeBio Initiates Long Term Debt Management Strategy and Announces Proposed Offering of Convertible Senior Notes to Refinance Senior Secured Debt

24/02/2025 - 22:09

- Long term debt management strategy will strengthen the balance sheet without increasing total liabilities - Refinancing term debt facility lowers interest expense, eliminates near-term amortization payments, and [...]

atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference

24/02/2025 - 22:10

NEW YORK and BERLIN, Feb. 24, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, [...]

Ultragenyx to Participate at Investor Conferences in March

24/02/2025 - 22:30

NOVATO, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and [...]

Travere Therapeutics to Participate at Upcoming Investor Conferences

24/02/2025 - 22:30

SAN DIEGO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that company management will participate in the following upcoming investor conferences in March: TD Cowen 45th [...]

Xilio Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

24/02/2025 - 22:30

WALTHAM, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living [...]

Precision Optics Announces Closing of $5.1 Million Offering of Common Stock to Fund Business Expansion

24/02/2025 - 22:30

GARDNER, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries [...]

Teladoc Health to Participate in Upcoming Investor Conference

24/02/2025 - 22:30

PURCHASE, NY, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer [...]

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting

24/02/2025 - 22:45

Advanced platforms for CROs, pharmaceutical and biotech companies seeking to enhance productivity HOLLISTON, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that it will [...]

Cronos Group Inc. to Hold 2024 Fourth Quarter and Full-Year Earnings Conference Call on February 27, 2025

24/02/2025 - 22:45

TORONTO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 fourth-quarter and full-year earnings conference call on Thursday, February 27, 2025 [...]

Hospital shooting highlights the dangers and violence nurses often face at work

23/02/2025 - 03:19

One in four nurses face workplace violence, a rate higher than police and correctional officers. SILVER SPRING, MD, Feb. 22, 2025 (GLOBE NEWSWIRE) -- SILVER SPRING, MD – The American Nurses Association (the association [...]

Bay Area Therapy Center Offers Specialized Therapy for Overcoming Communication and Relationship Issues in San Francisco

23/02/2025 - 13:43

Offering Expert Therapy Services in San Francisco, the Center Provides Tailored Solutions for Jealousy, Attachment, and More SAN FRANCISCO, Feb. 23, 2025 (GLOBE NEWSWIRE) -- Bay Area Therapy Center is excited to [...]

IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference

23/02/2025 - 18:07

• Findings support the development of a novel peptide vaccine targeting the immunosuppressive effects of Transforming Growth Beta (TGF- β ) in solid tumors NEW YORK, Feb. 23, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq [...]

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

21/02/2025 - 23:15

SAN CARLOS, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal [...]

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

22/02/2025 - 08:20

Teva hosting investor call Monday, February 24 at 8:00 a.m. U.S. ET New detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug in all pre-specified subgroups across the different [...]

Communiqué de presse : ECCO 2025 : de nouvelles données sur le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de Crohn

22/02/2025 - 08:30

ECCO 2025 : de nouvelles données sur le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de Crohn De nouvelles données détaillées de l’ [...]

Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease

22/02/2025 - 08:30

ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease New detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug in all pre- [...]

Bay Area Cognitive Behavioral Therapy Center Expands Treatment Offerings with Acceptance and Commitment Therapy

22/02/2025 - 13:42

Bay Area Therapy Center Expand Treatment Options Offering Comprehensive Mental Health Services in San Francisco SAN FRANCISCO, Feb. 22, 2025 (GLOBE NEWSWIRE) -- The Bay Area Cognitive Behavioral Therapy Center , a [...]